{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:41:37Z","timestamp":1784302897865,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T00:00:00Z","timestamp":1466553600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003356","name":"Gazi \u00dcniversitesi","doi-asserted-by":"publisher","award":["01\/2012-66"],"award-info":[{"award-number":["01\/2012-66"]}],"id":[{"id":"10.13039\/501100003356","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00223-016-0163-1","type":"journal-article","created":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T23:46:20Z","timestamp":1466639180000},"page":"365-372","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["RANKL\/Osteoprotegerin System and Bone Turnover in Hashimoto Thyroiditis"],"prefix":"10.1007","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0299-6596","authenticated-orcid":false,"given":"Ceyla","family":"Konca Degertekin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozlem","family":"Turhan Iyidir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Aktas Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sehri","family":"Elbeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozge Tugce","family":"Pasaoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice","family":"Pasaoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuri","family":"Cak\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metin","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,22]]},"reference":[{"key":"163_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1196\/annals.1365.035","volume":"1092","author":"DJ Hadjidakis","year":"2006","unstructured":"Hadjidakis DJ, Androulakis II (2006) Bone remodeling. Ann N Y Acad Sci 1092:385\u2013396. doi: 10.1196\/annals.1365.035","journal-title":"Ann N Y Acad Sci"},{"issue":"5\u20136","key":"163_CR2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s001090100226","volume":"79","author":"LC Hofbauer","year":"2001","unstructured":"Hofbauer LC, Heufelder AE (2001) Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. J Mol Med 79(5\u20136):243\u2013253","journal-title":"J Mol Med"},{"issue":"4","key":"163_CR3","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/jama.292.4.490","volume":"292","author":"LC Hofbauer","year":"2004","unstructured":"Hofbauer LC, Schoppet M (2004) Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases. JAMA 292(4):490\u2013495. doi: 10.1001\/jama.292.4.490","journal-title":"JAMA"},{"key":"163_CR4","doi-asserted-by":"publisher","first-page":"638727","DOI":"10.1155\/2013\/638727","volume":"2013","author":"J Gorka","year":"2013","unstructured":"Gorka J, Taylor-Gjevre RM, Arnason T (2013) Metabolic and clinical consequences of hyperthyroidism on bone density. Int J endocrinol 2013:638727. doi: 10.1155\/2013\/638727","journal-title":"Int J endocrinol"},{"issue":"1","key":"163_CR5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archinte.1986.00360130058007","volume":"146","author":"JM Coindre","year":"1986","unstructured":"Coindre JM, David JP, Riviere L, Goussot JF, Roger P, de Mascarel A, Meunier PJ (1986) Bone loss in hypothyroidism with hormone replacement: a histomorphometric study. Arch Intern Med 146(1):48\u201353","journal-title":"Arch Intern Med"},{"issue":"1","key":"163_CR6","first-page":"56","volume":"86","author":"L Mosekilde","year":"1978","unstructured":"Mosekilde L, Melsen F (1978) Morphometric and dynamic studies of bone changes in hypothyroidism. Acta pathol et microbiol Scand Sect A, Pathol 86(1):56\u201362","journal-title":"Acta pathol et microbiol Scand Sect A, Pathol"},{"issue":"3","key":"163_CR7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0221-8747(81)90006-0","volume":"3","author":"J Kragstrup","year":"1981","unstructured":"Kragstrup J, Melsen F, Mosekilde L (1981) Effects of thyroid hormone(s) on mean wall thickness of trabecular bone packets. Metab bone dis relat res 3(3):181\u2013185","journal-title":"Metab bone dis relat res"},{"issue":"5","key":"163_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1089\/105072502760043503","volume":"12","author":"P Vestergaard","year":"2002","unstructured":"Vestergaard P, Mosekilde L (2002) Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid : Off J AmThyroid Assoc 12(5):411\u2013419. doi: 10.1089\/105072502760043503","journal-title":"Thyroid : Off J AmThyroid Assoc"},{"issue":"3","key":"163_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00223-005-0068-x","volume":"77","author":"P Vestergaard","year":"2005","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2005) Influence of hyper- and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk. Calcif Tissue Int 77(3):139\u2013144. doi: 10.1007\/s00223-005-0068-x","journal-title":"Calcif Tissue Int"},{"issue":"20","key":"163_CR10","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1001\/jama.2015.5161","volume":"313","author":"MR Blum","year":"2015","unstructured":"Blum MR, Bauer DC, Collet TH, Fink HA, Cappola AR, da Costa BR, Wirth CD, Peeters RP, Asvold BO, den Elzen WP, Luben RN, Imaizumi M, Bremner AP, Gogakos A, Eastell R, Kearney PM, Strotmeyer ES, Wallace ER, Hoff M, Ceresini G, Rivadeneira F, Uitterlinden AG, Stott DJ, Westendorp RG, Khaw KT, Langhammer A, Ferrucci L, Gussekloo J, Williams GR, Walsh JP, Juni P, Aujesky D, Rodondi N, Thyroid Studies C (2015) Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA 313(20):2055\u20132065. doi: 10.1001\/jama.2015.5161","journal-title":"JAMA"},{"issue":"5","key":"163_CR11","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.metabol.2007.01.004","volume":"56","author":"M Giusti","year":"2007","unstructured":"Giusti M, Cecoli F, Fazzuoli L, De Franchis V, Ceresola E, Ferone D, Mussap M, Minuto F (2007) Serum osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand levels in patients with a history of differentiated thyroid carcinoma: a case-controlled cohort study. Metab, Clin Exp 56(5):699\u2013707. doi: 10.1016\/j.metabol.2007.01.004","journal-title":"Metab, Clin Exp"},{"issue":"5","key":"163_CR12","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1365-2265.2008.03263.x","volume":"69","author":"X Guang-da","year":"2008","unstructured":"Guang-da X, Hui-ling S, Jie H (2008) Changes in endothelial function and its association with plasma osteoprotegerin in hypothyroidism with exercise-induced silent myocardial ischaemia. Clin Endocrinol 69(5):799\u2013803. doi: 10.1111\/j.1365-2265.2008.03263.x","journal-title":"Clin Endocrinol"},{"issue":"10","key":"163_CR13","doi-asserted-by":"publisher","first-page":"5765","DOI":"10.1210\/jc.2005-0562","volume":"90","author":"X Guang-da","year":"2005","unstructured":"Guang-da X, Hui-ling S, Zhi-song C, Lin-shuang Z (2005) Changes in plasma concentrations of osteoprotegerin before and after levothyroxine replacement therapy in hypothyroid patients. J clin endocrinol metab 90(10):5765\u20135768. doi: 10.1210\/jc.2005-0562","journal-title":"J clin endocrinol metab"},{"issue":"3","key":"163_CR14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1530\/eje.1.01870","volume":"152","author":"T Nagasaki","year":"2005","unstructured":"Nagasaki T, Inaba M, Jono S, Hiura Y, Tahara H, Shirakawa K, Onoda N, Ishikawa T, Ishimura E, Nishizawa Y (2005) Increased levels of serum osteoprotegerin in hypothyroid patients and its normalization with restoration of normal thyroid function. Eur J endocrinol\/Eur Fed Endocr Soc 152(3):347\u2013353. doi: 10.1530\/eje.1.01870","journal-title":"Eur J endocrinol\/Eur Fed Endocr Soc"},{"issue":"6812","key":"163_CR15","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/35046102","volume":"408","author":"H Takayanagi","year":"2000","unstructured":"Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, Taniguchi T (2000) T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 408(6812):600\u2013605. doi: 10.1038\/35046102","journal-title":"Nature"},{"issue":"11","key":"163_CR16","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nrrheum.2012.167","volume":"8","author":"H Takayanagi","year":"2012","unstructured":"Takayanagi H (2012) New developments in osteoimmunology. Nat Rev Rheumatol 8(11):684\u2013689. doi: 10.1038\/nrrheum.2012.167","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"163_CR17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/thy.2000.10.251","volume":"10","author":"OM Pedersen","year":"2000","unstructured":"Pedersen OM, Aardal NP, Larssen TB, Varhaug JE, Myking O, Vik-Mo H (2000) The value of ultrasonography in predicting autoimmune thyroid disease. Thyroid : Off J Am Thyroid Assoc 10(3):251\u2013259","journal-title":"Thyroid : Off J Am Thyroid Assoc"},{"issue":"8","key":"163_CR18","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1089\/thy.2010.0457","volume":"21","author":"R Ma","year":"2011","unstructured":"Ma R, Morshed S, Latif R, Zaidi M, Davies TF (2011) The influence of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on osteoclastogenesis. Thyroid : Off J AmThyroid Assoc 21(8):897\u2013906. doi: 10.1089\/thy.2010.0457","journal-title":"Thyroid : Off J AmThyroid Assoc"},{"issue":"4","key":"163_CR19","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s00223-003-0033-5","volume":"74","author":"F Varga","year":"2004","unstructured":"Varga F, Spitzer S, Klaushofer K (2004) Triiodothyronine (T3) and 1,25-dihydroxyvitamin D3 (1,25D3) inversely regulate OPG gene expression in dependence of the osteoblastic phenotype. Calcif Tissue Int 74(4):382\u2013387. doi: 10.1007\/s00223-003-0033-5","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"163_CR20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1530\/EJE-06-0649","volume":"156","author":"JI Botella-Carretero","year":"2007","unstructured":"Botella-Carretero JI, Alvarez-Blasco F, San Millan JL, Escobar-Morreale HF (2007) Thyroid hormone deficiency and postmenopausal status independently increase serum osteoprotegerin concentrations in women. Eur J endocrinol\/Eur Fed Endocr Soc 156(5):539\u2013545. doi: 10.1530\/EJE-06-0649","journal-title":"Eur J endocrinol\/Eur Fed Endocr Soc"},{"issue":"4","key":"163_CR21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.14310\/horm.2002.1111026","volume":"6","author":"M Giusti","year":"2007","unstructured":"Giusti M, Cecoli F, Ghiara C, Rubinacci A, Villa I, Cavallero D, Mazzuoli L, Mussap M, Lanzi R, Minuto F (2007) Recombinant human thyroid stimulating hormone does not acutely change serum osteoprotegerin and soluble receptor activator of nuclear factor-kappaBeta ligand in patients under evaluation for differentiated thyroid carcinoma. Hormones (Athens) 6(4):304\u2013313","journal-title":"Hormones (Athens)"},{"issue":"1\u20133","key":"163_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.regpep.2008.02.004","volume":"148","author":"MF Heymann","year":"2008","unstructured":"Heymann MF, Riet A, Le Goff B, Battaglia S, Paineau J, Heymann D (2008) OPG, RANK and RANK ligand expression in thyroid lesions. Regul Pept 148(1\u20133):46\u201353. doi: 10.1016\/j.regpep.2008.02.004","journal-title":"Regul Pept"},{"issue":"9","key":"163_CR23","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1007\/s00268-011-1185-5","volume":"35","author":"SK Sood","year":"2011","unstructured":"Sood SK, Balasubramanian S, Higham S, Fernando M, Harrison B (2011) Osteoprotegerin (OPG) and related proteins (RANK, RANKL and TRAIL) in thyroid disease. World J Surg 35(9):1984\u20131992. doi: 10.1007\/s00268-011-1185-5","journal-title":"World J Surg"},{"issue":"4","key":"163_CR24","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/jcb.10242","volume":"86","author":"LC Hofbauer","year":"2002","unstructured":"Hofbauer LC, Kluger S, Kuhne CA, Dunstan CR, Burchert A, Schoppet M, Zielke A, Heufelder AE (2002) Detection and characterization of RANK ligand and osteoprotegerin in the thyroid gland. J Cell Biochem 86(4):642\u2013650. doi: 10.1002\/jcb.10242","journal-title":"J Cell Biochem"},{"issue":"6656","key":"163_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/36593","volume":"390","author":"DM Anderson","year":"1997","unstructured":"Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390(6656):175\u2013179. doi: 10.1038\/36593","journal-title":"Nature"},{"issue":"3","key":"163_CR26","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1172\/JCI19872","volume":"113","author":"NA Sims","year":"2004","unstructured":"Sims NA, Jenkins BJ, Quinn JM, Nakamura A, Glatt M, Gillespie MT, Ernst M, Martin TJ (2004) Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways. J Clin Investig 113(3):379\u2013389. doi: 10.1172\/JCI19872","journal-title":"J Clin Investig"},{"issue":"27","key":"163_CR27","doi-asserted-by":"crossref","first-page":"19301","DOI":"10.1074\/jbc.274.27.19301","volume":"274","author":"CA O\u2019Brien","year":"1999","unstructured":"O\u2019Brien CA, Gubrij I, Lin SC, Saylors RL, Manolagas SC (1999) STAT3 activation in stromal\/osteoblastic cells is required for induction of the receptor activator of NF-kappaB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D3 or parathyroid hormone. J Biol Chem 274(27):19301\u201319308","journal-title":"J Biol Chem"},{"issue":"7","key":"163_CR28","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/s0192-0561(00)00012-6","volume":"22","author":"AJ Klecha","year":"2000","unstructured":"Klecha AJ, Genaro AM, Lysionek AE, Caro RA, Coluccia AG, Cremaschi GA (2000) Experimental evidence pointing to the bidirectional interaction between the immune system and the thyroid axis. Int J Immunopharmacol 22(7):491\u2013500 10.1016\/s0192-0561(00)00012-6 . doi:","journal-title":"Int J Immunopharmacol"},{"issue":"1","key":"163_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1677\/joe.1.06137","volume":"189","author":"AJ Klecha","year":"2006","unstructured":"Klecha AJ, Genaro AM, Gorelik G, Barreiro Arcos ML, Silberman DM, Schuman M, Garcia SI, Pirola C, Cremaschi GA (2006) Integrative study of hypothalamus-pituitary-thyroid-immune system interaction: thyroid hormone-mediated modulation of lymphocyte activity through the protein kinase C signaling pathway. J Endocrinol 189(1):45\u201355. doi: 10.1677\/joe.1.06137","journal-title":"J Endocrinol"},{"issue":"3","key":"163_CR30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00007611-199503000-00019","volume":"88","author":"PS Schoenfeld","year":"1995","unstructured":"Schoenfeld PS, Myers JW, Myers L, LaRocque JC (1995) Suppression of cell-mediated immunity in hypothyroidism. South Med J 88(3):347\u2013349","journal-title":"South Med J"},{"issue":"1","key":"163_CR31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1210\/jcem.82.1.3641","volume":"82","author":"P Lakatos","year":"1997","unstructured":"Lakatos P, Foldes J, Horvath C, Kiss L, Tatrai A, Takacs I, Tarjan G, Stern PH (1997) Serum interleukin-6 and bone metabolism in patients with thyroid function disorders. J Clin Endocrinol Metab 82(1):78\u201381. doi: 10.1210\/jcem.82.1.3641","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"163_CR32","first-page":"435","volume":"84","author":"A Siddiqi","year":"1999","unstructured":"Siddiqi A, Monson JP, Wood DF, Besser GM, Burrin JM (1999) Serum cytokines in thyrotoxicosis. J clin endocrinol metabol 84(2):435\u2013439","journal-title":"J clin endocrinol metabol"},{"issue":"1","key":"163_CR33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2265.2002.01578.x","volume":"57","author":"A Akalin","year":"2002","unstructured":"Akalin A, Colak O, Alatas O, Efe B (2002) Bone remodelling markers and serum cytokines in patients with hyperthyroidism. Clin Endocrinol 57(1):125\u2013129","journal-title":"Clin Endocrinol"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-016-0163-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-016-0163-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-016-0163-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T12:53:20Z","timestamp":1498308800000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-016-0163-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,22]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["163"],"URL":"https:\/\/doi.org\/10.1007\/s00223-016-0163-1","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,22]]}}}